Charles Schwab
ONEM

Charles Schwab’s 1Life Healthcare ONEM Stock Holding History

Charles Schwab’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,275,089
Closed -$21.3M – 3625
2022
Q4 		$21.3M Buy
1,275,089
+29,634
+2% +$501K 0.01% 1386
2022
Q3 		$21.4M Buy
1,245,455
+7,150
+0.6% +$112K 0.01% 1321
2022
Q2 		$9.71M Buy
1,238,305
+126,106
+11% +$1.08M ﹤0.01% 1846
2022
Q1 		$12.3M Buy
1,112,199
+21,495
+2% +$241K ﹤0.01% 1833
2021
Q4 		$19.2M Buy
1,090,704
+283,398
+35% +$5.5M 0.01% 1618
2021
Q3 		$16.3M Sell
807,306
-12,313
-2% -$317K 0.01% 1731
2021
Q2 		$27.1M Buy
819,619
+105,538
+15% +$3.98M 0.01% 1338
2021
Q1 		$27.9M Buy
714,081
+46,839
+7% +$2.2M 0.01% 1242
2020
Q4 		$29.1M Buy
667,242
+34,215
+5% +$1.17M 0.01% 1127
2020
Q3 		$18M Buy
633,027
+401,591
+174% +$12.7M 0.01% 1283
2020
Q2 		$8.41M Buy
231,436
+190,600
+467% +$5.37M ﹤0.01% 1746
2020
Q1 		$742K Buy
+40,836
New +$895K ﹤0.01% 2566

Charles Schwab's ONEM Position: Q1 2023 in Review

Charles Schwab sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 1,275,089 shares — an estimated $21.3M sold.

Charles Schwab first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $29.1M in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Charles Schwab reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Charles Schwab sold 1,275,089 1Life Healthcare shares in Q1 2023, an estimated $21.3M.
  • Charles Schwab first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • Charles Schwab's 1Life Healthcare position peaked at $29.1M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.